MedTrace Logo

Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck Cancer

NCT01621048 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-04-03

No results posted yet for this study

Summary

Radiotherapy plays an important role in the curative treatment of head and neck cancer. This treatment however is associated with significant acute and late toxicity with xerostomia and dysphagia severely implicating the patient's quality of life. With highly conformal radiotherapy techniques it is possible to decrease de dose to the organs at risk while maintaining adequate doses to the tumour. In order to adequately register the effect of these techniques it is imperative to obtain standardized information on the acute and late treatment effects. With this study the investigators want to evaluate this toxicity using standardized and validated questionnaires during follow-up. This data will then be correlated to the doses delivered to the specific organs at risk.

Conditions

  • Head and Neck Neoplasms
  • Xerostomia
  • Deglutition Disorders

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Sandra Nuyts, M.D., Ph.D · Department of Radiotherapy, UZ Gasthuisberg Leuven

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01621048 on ClinicalTrials.gov